Beijing Hotgen Biotech Co., Ltd.

Location

Beijing

Founded

2005-10-23

Risk Signals

7 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., In Vitro and In Vivo Diagnostic Substances), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Recent Articles about Beijing Hotgen Biotech Co., Ltd.

Live alerts from global media, monitored by Business Radar

Germany's new crown self-test reagents were sold out, and overseas antigen reagents were welcomed again!

2021-03-08 (sogou.com)

Germany's new crown self-test reagents were sold out, and overseas antigen reagents were welcomed again!

(Beijing Hotgen Biotech Co., Ltd) In addition, many Chinese manufacturers have also successfully developed antigen detection reagents for the new crown, such as: (The examples here are incomplete, welcome to add them) ...

Read more

Never miss a headline about Beijing Hotgen Biotech Co., Ltd.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages